Evidence map›Paper›PMID 37193692›Full record

ArticleNature communications2023

A pesticide and iPSC dopaminergic neuron screen identifies and classifies Parkinson-relevant pesticides.

Kimberly C Paul, Richard C Krolewski, Edinson Lucumi Moreno, Jack Blank, Kristina M Holton, Tim Ahfeldt, Melissa Furlong, Yu Yu, Myles Cockburn, Laura K Thompson and 9 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
19.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 94 citations in OpenAlex.

  1. Review
  2. Cellular and systemic modifiers of alpha-synuclein proteostasis.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Dual-Risk axis:Journal of Parkinson's disease · 2026
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 1 country.

Kimberly C Paul *Department of Neurology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA. kimberlp@ucla.edu.ORCID http://orcid.org/0000-0002-4476-2352
Richard C Krolewski *Division of Movement Disorders, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA.ORCID http://orcid.org/0000-0001-5974-079X
Edinson Lucumi MorenoDivision of Movement Disorders, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA.
Jack BlankPrime Medicine, Inc, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-1674-0444
Kristina M HoltonDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Tim AhfeldtRecursion Pharmaceuticals, Salt Lake City, UT, USA.
Melissa FurlongUniversity of Arizona, Mel and Enid Zuckerman College of Public Health, Tucson, AZ, USA.
Yu YuUCLA Center for Health Policy Research, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-8717-0245
Myles CockburnDepartment of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Laura K ThompsonDepartment of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0001-9581-9032
Alexander KreymermanDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Elisabeth M Ricci-BlairDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Yu Jun LiDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Heer B PatelDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.
Richard T LeeDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA.ORCID http://orcid.org/0000-0003-4687-1381
Jeff BronsteinDepartment of Neurology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA.
Lee L RubinDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA. lee_rubin@harvard.edu.ORCID http://orcid.org/0000-0002-8658-841X
Vikram KhuranaDivision of Movement Disorders, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 02115, USA. vkhurana@bwh.harvard.edu.ORCID http://orcid.org/0000-0002-4018-5527
Beate RitzDepartment of Neurology, UCLA David Geffen School of Medicine, Los Angeles, CA, USA. britz@ucla.edu.ORCID http://orcid.org/0000-0001-6976-7339
Harvard University · USBrigham and Women's Hospital · USUniversity of California, Los Angeles · USArrien Pharmaceuticals (United States) · USUniversity of Southern California · USBroad Institute · USHarvard Stem Cell Institute · USUniversity of Arizona · US

Funding

SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI Nathan J Cherrington · 1994 to 2026
$36.7M
PARKINSON'S DISEASES SUSCEPTIBILITY GENES AND PESTICIDESR01ES010544 · NIEHS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI RITZ, BEATE R. · 2000 to 2015
$5.7M
Molecular Quiescence and Cardiomyocyte MaturationR01HL151684 · NHLBI · HARVARD UNIVERSITY · PI LEE, RICHARD T · 2020 to 2023
$1.7M
The role of mitochondrial DNA mutations in chemotherapy induced cardiomyopathyF32HL154644 · NHLBI · STANFORD UNIVERSITY · PI KREYMERMAN, ALEXANDER · 2020 to 2023
$237k
NHLBI NIH HHS F32 HL154644NHLBI NIH HHS R01 HL151684NIEHS NIH HHS P30 ES006694NIEHS NIH HHS R01 ES010544
6 · The paper itself

Abstract

Parkinson's disease (PD) is a complex neurodegenerative disease with etiology rooted in genetic vulnerability and environmental factors. Here we combine quantitative epidemiologic study of pesticide exposures and PD with toxicity screening in dopaminergic neurons derived from PD patient induced pluripotent stem cells (iPSCs) to identify Parkinson's-relevant pesticides. Agricultural records enable investigation of 288 specific pesticides and PD risk in a comprehensive, pesticide-wide association study. We associate long-term exposure to 53 pesticides with PD and identify co-exposure profiles. We then employ a live-cell imaging screening paradigm exposing dopaminergic neurons to 39 PD-associated pesticides. We find that 10 pesticides are directly toxic to these neurons. Further, we analyze pesticides typically used in combinations in cotton farming, demonstrating that co-exposures result in greater toxicity than any single pesticide. We find trifluralin is a driver of toxicity to dopaminergic neurons and leads to mitochondrial dysfunction. Our paradigm may prove useful to mechanistically dissect pesticide exposures implicated in PD risk and guide agricultural policy.

Indexed as

Induced Pluripotent Stem CellsNeurodegenerative DiseasesParkinson DiseasePesticidesDopaminergic NeuronsHumansPesticides

Identifiers

PMID37193692
PMCPMC10188516
OpenAlexW4376871337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.